Allspring Global Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $52.4M | Sell |
|
|||||
|
2025
Q2 | $57.3M | Buy |
|
|||||
|
2025
Q1 | $41.5M | Sell |
|
|||||
|
2024
Q4 | $66.2M | Sell |
|
|||||
|
2024
Q3 | $79.5M | Sell |
|
|||||
|
2024
Q2 | $97.8M | Buy |
|
|||||
|
2024
Q1 | $69.9M | Buy |
|
|||||
|
2023
Q4 | $54M | Buy |
|
|||||
|
2023
Q3 | $25.4M | Sell |
|
|||||
|
2023
Q2 | $34.9M | Buy |
|
|||||
|
2023
Q1 | $34.2M | Sell |
|
|||||
|
2022
Q4 | $59.3M | Sell |
|
|||||
|
2022
Q3 | $57.3M | Buy |
|
|||||
|
2022
Q2 | $11M | Sell |
|
|||||
|
2022
Q1 | $19M | Sell |
|
|||||
|
2021
Q4 | $17.5M | Buy |
|